Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil is the only drug proven to improve female hair loss, and dextroamphetamine sulfate may be a new treatment for certain types of hair loss.

iNOS contributes to hair loss in obese diabetic mice and blocking it may encourage hair growth.

Appropriate zinc levels may help prevent hair loss in university students.

Aging skin is affected by inflammation, reduced stem cell function, and slower wound healing.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

miR-29 is a key factor that accelerates aging.

Air pollution worsens skin diseases and aging by causing inflammation and oxidative stress.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Different types of male pattern baldness have unique inflammation-related protein patterns.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Some cats with sudden hair loss and tiredness might have cancer-related alopecia.

Men with androgenetic alopecia, or hair loss, often have abnormal blood flow in their small blood vessels, which might be linked to inflammation and stress.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Minoxidil may help treat hair loss by reducing inflammation-related gene activity in skin cells.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

AGEs may cause hair loss by increasing inflammation in hair follicles.

EGFR is crucial for preventing hair follicle inflammation and hair loss.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

The document concludes that diagnosing hair loss requires evaluating multiple histological features, as no single feature is definitive on its own.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

A virus protein can activate a pathway that may lead to abnormal hair follicle development.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Psoriasis lesions have fewer and smaller oil glands, which might affect the condition's development.

Mild oxidative stress can prevent hair loss from chemotherapy.

CGF therapy may help hair regrowth and improve scars in DLE patients.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Some breast cancer chemotherapy can cause permanent hair loss.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.